← Open Payments lookup

LAURA THOMSON: Open Payments

NPI 1710358650 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$890 in 38 payments from 10 companies in 2025. Trend: 2023 $17,097 · 2024 $4,051 · 2025 $890

Food & beverage: $707Education: $183
CompanyPaymentsAmount
ABBVIE INC.23$353
Teva Pharmaceuticals USA, Inc.4$215
Axsome Therapeutics, Inc.3$159
Vanda Pharmaceuticals Inc.2$49
GlaxoSmithKline, LLC.1$32
Alkermes, Inc.1$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18
Supernus Pharmaceuticals, Inc.1$16
E.R. Squibb & Sons, L.L.C.1$15
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: VRAYLAR, Auvelity, HETLIOZ, TRELEGY ELLIPTA, AUSTEDO XR, ARISTADA, XIFAXAN, Qelbree.

Industry payments across KY — which companies pay providers there.